Main Article Content

Ghazala Shaheen
Mudassar Mohiuddin
kinza khan
Atia Iqbal
Hafiz Muhammad Imran
Muhammad Khalid Mansoor
Rubaida Mehmood
Muhammad Yaqoob
Tayyaba Asghar


Hepatocellular Carcinoma, Real Time PCR, Southern Punjab, Viral Load, Hepatitis B virus


Hepatitis B virus (HBV) can lead to the early onset of severe and prolonged liver infections that result in liver cirrhosis and hepatocellular carcinoma in infected individuals. These infections are a global concern especially for developing countries like Pakistan. This study targeted local population of densely populated city Multan, Southern Punjab, who were found seropositive for hepatic infections, viz, hepatitis B (HBV). Accordingly, 176 seropositive samples (124 male and 52 female) were confirmed via Real time PCR. The Real time PCR detected and confirmed viral DNA in 81.8% (144) samples while remaining were negative. In case of male population, 105 individuals were positive, having high viral load in 4/105, moderate viral load in 78/105 and low viral load in remaining 23 individuals. In female population, among 39 positive cases, 3 females were found having high viral load, 31 having moderate and 5 with low viral load. High viral load could be related with the emergence of serious liver disease in both genders. The prevalence of HBV was significantly higher in <25 years age-group than 26-50 years and 51-75 years age groups (P<0.05). The Southern Punjab population of Pakistan has a high prevalence rate of HBV due to lower literacy rate, lack of effective blood screening facilities, poverty, and ignorance regarding HBV risk factors. The high frequency of HBV-infection in the studied area is of concern and highlights the need for adopting proper preventative measures. It is proposed that more initiatives should be taken to educate the general population and training of health care workers regarding the adverse outcomes for HBV and how it transmits.

Abstract 212 | PDF Downloads 96


1. Asad M, Zafar H, Bukhari K T and Yasir I. 2013. Frequency of hepatitis B & C viral infections amongst students of a medical school of islamabad, pakistan. Asian Journal of Agricultural and Biology, 1(4), 183-186.
2. Awan Z U R, Shah A H, Khan S, Rahman S U and Rahman H M U. 2012. Molecular prevalence of Hepatitis B virus infection in Khyber Pakhtunkhwa, Pakistan. Int J Med Med Sci, 4, 123-127.
3. Banik S, Datta A, Ghosh A, Ghosh K Y and Debi H. 2022. The prevalence of hepatitis B virus infection in Bangladesh: A systematic review and meta-analysis. Epidemiology & Infection, 1-25.
4. Bukhari K T and Zafar H. 2013. Blood complete picture examination; A surrogate test for screening hepatitis C viral infection. Asian J Agri Biol, 1(2), 76-78.
5. Caliendo A M, Valsamakis A, Bremer J W, Ferreira-Gonzalez A, Granger S, Sabatini L, Tsongalis G J, Wang Y F, Yen-Lieberman B and Young S. 2011. Multilaboratory evaluation of real-time PCR tests for hepatitis B virus DNA quantification. Journal of clinical microbiology, 49(8), 2854-2858.
6. Campos-Valdez M, Monroy-Ramírez H C, Armendáriz-Borunda J and Sánchez-Orozco L V. 2021. Molecular mechanisms during hepatitis B infection and the effects of the virus variability. Viruses, 13(6), 1167.
7. Chen C J, Yang H I, Su J, Jen C L, You S L, Lu S N, Huang G T and Iloeje U H. 2006. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. Jama, 295(1), 65-73.
8. Chen G, Lin W, Shen F, Iloeje U H, London W T and Evans A A. 2006. Past HBV viral load as predictor of mortality and morbidity from HCC and chronic liver disease in a prospective study. Am J Gastroenterol, 101(8), 1797-1803.
9. Eke A C, Eke U A, Okafor C I, Ezebialu I U and Ogbuagu C. 2011. Prevalence, correlates and pattern of hepatitis B surface antigen in a low resource setting. Virology journal, 8(1), 1-8.
10. Fusco M, Girardi E, Piselli P, Palombino R, Polesel J, Maione C, Scognamiglio P, Pisanti F A, Solmone M and Di Cicco P. 2008. Epidemiology of viral hepatitis infections in an area of southern Italy with high incidence rates of liver cancer. European Journal of Cancer, 44(6), 847-853.
11. Gholamreza R, Shahryar S, Abbasali K, Hamidreza J P, __Abdolvahab M, Khodaberdi K, Danyal R and Nafiseh A. 2007. Seroprevalence of hepatitis B virus and its co-infection with hepatitis D virus and hepatitis C virus in Iranian adult population. Indian Journal of Medical Sciences, 61(5), 263-268.
12. Gullett J C and Nolte F S. 2015. Quantitative nucleic acid amplification methods for viral infections. Clinical chemistry, 61(1), 72-78.
13. Hebo H J, Gemeda D H and Abdusemed K A. 2019. Hepatitis B and C viral infection: prevalence, knowledge, attitude, practice, and occupational exposure among healthcare workers of Jimma University Medical Center, southwest Ethiopia. The Scientific World Journal, 2019.
14. Hochberger S, Althof D, de Schrott R G, Nachbaur N, Röck H and Leying H. 2006. Fully automated quantitation of Hepatitis B virus (HBV) DNA in human plasma by the COBAS® AmpliPrep/COBAS® TaqMan® System. Journal of clinical virology, 35(4), 373-380.
15. Hochberger S, Althof D, Gallegos de Schrott R, Nachbaur N, Röck H and Leying H. 2006. Fully automated quantitation of hepatitis B virus (HBV) DNA in human plasma by the COBAS AmpliPrep/COBAS TaqMan system. J Clin Virol, 35(4), 373-380. /j.jcv.2006.01.003
16. Idrees M, Awan Z, Rafique S, Rehman I-u, Akbar H, Butt S, Manzoor S, Khan L A, Munir S and Afzal S. 2010. Hepatitis B virus YMDD-motif mutations with emergence of lamivudine-resistant mutants: a threat to recovery. Gastroenterology and Hepatology from bed to bench, 3(3).
17. Iloeje U H, Yang H I, Jen C L, Su J, Wang L Y, You S L and Chen C J. 2007. Risk and predictors of mortality associated with chronic hepatitis B infection. Clin Gastroenterol Hepatol, 5(8), 921-931.
18. Iloeje U H, Yang H I, Su J, Jen C L, You S L and Chen C J. 2006. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology, 130(3), 678-686.
19. Janahi E M. 2014. Prevalence and risk factors of hepatitis B virus infection in Bahrain, 2000 through 2010. PloS one, 9(2), e87599.
20. Khan F, Akbar H, Idrees M, Khan H, Shahzad K and Kayani M A. 2011a. The prevalence of HBV infection in the cohort of IDPs of war against terrorism in Malakand Division of Northern Pakistan. BMC infectious diseases, 11(1), 176.
21. Khan F, Akbar H, Idrees M, Khan H, Shahzad K and Kayani M A. 2011b. The prevalence of HBV infection in the cohort of IDPs of war against terrorism in Malakand Division of Northern Pakistan. BMC infectious diseases, 11(1), 1-6.
22. Khan F, Shams S, Qureshi I D, Israr M, Khan H, Sarwar M T and Ilyas M. 2011. Hepatitis B virus infection among different sex and age groups in Pakistani Punjab. Virology journal, 8(1), 1-5.
23. Kitandwe P K, Muyanja E, Nakaweesa T, Nanvubya A, Ssetaala A, Mpendo J, Okech B, Bagaya B S, Kiwanuka N and Price M A. 2021. Hepatitis B prevalence and incidence in the fishing communities of Lake Victoria, Uganda: a retrospective cohort study. BMC public health, 21(1), 1-8.
24. Loomba R and Liang T J. 2017. Hepatitis B reactivation associated with immune suppressive and biological modifier therapies: current concepts, management strategies, and future directions. Gastroenterology, 152(6), 1297-1309.
25. Mazhar M, Sikandar M and Mahmood J. 2021. Molecular analysis of HCV real time pcr in multan Pakistan. J Virology Anti Res, 10(4), 53.
26. Mirza I A, Kazmi S M H and Janjua A N. 2007. Frequency of hepatitis B surface antigen and anti-HCV in young adults-experience in southern Punjab. J Coll Physicians Surg Pak, 17(2), 114-115.
27. Montella M, D’Arena G, Crispo A, Capunzo M, Nocerino F, Grimaldi M, Barbieri A, D’Ursi A M, Tecce M F and Amore A. 2015. Role of sex hormones in the development and progression of hepatitis B virus-associated hepatocellular carcinoma. International Journal of Endocrinology, 2015.
28. Motayo B O, Faneye A O, Udo U A, Olusola B A, Ezeani I and Ogiogwa J I. 2015. Seroprevalence of transfusion transmissible infections (TTI), in first time blood donors in Abeokuta, Nigeria. African health sciences, 15(1), 19-24.
29. Nevola R, Messina V, Marrone A, Coppola N, Rescigno C, Esposito V, Sangiovanni V, Claar E, Pisaturo M, Fusco F M, Rosario P, Izzi A, Pisapia R, Rosato V, Maggi P and Adinolfi L E. 2022. Epidemiology of HCV and HBV in a High Endemic Area of Southern Italy: Opportunities from the COVID-19 Pandemic—Standardized National Screening or One Tailored to Local Epidemiology? Biology, 11(4), 609.
30. Onu E N, Oseni O M-L, Peninnah O Z, Azi C I, Edenya O O, Akpa C O, Onu M E, Sunday N T and Emmanuel E O. 2023. Prevalence and Viral Load Determination of Hepatitis B Virus among Hiv Seropositive Patients Attending Kogi State Specialist Hospital Lokoja, Kogi State. Open Journal of Applied Sciences, 13(3), 288-301.
31. Pallavi K, Sravani D, Durga S, Durga S, Pavan P, Babu P and Raviteja K. 2017. Hepatitis review on current and future scenario. J In Silico In Vitro Pharmacol, 3(1), 1-5.
32. Rasheed M A, Tariq F, Afzal S and Mannanv S. 2017. In silico analysis of fragile histidine triad involved in regression of carcinoma. JPMA. The Journal of the Pakistan Medical Association, 67(4), 616-621.
33. Ruggieri A, Gagliardi M C and Anticoli S. 2018. Sex-dependent outcome of hepatitis B and C viruses infections: synergy of sex hormones and immune responses? Frontiers in Immunology, 9, 2302.
34. Samo A A, Laghari Z A, Baig N M and Khoso G M. 2020. Prevalence and Risk Factors Associated with Hepatitis B and C in Nawabshah, Sindh, Pakistan. Am J Trop Med Hyg, 104(3), 1101-1105.
35. Shah N, Shah J, Jhaveri P, Patel K, Shah C and Shah N. 2013. Seroprevalence of HBV, HCV, HIV and syphilis among blood donors at a tertiary care teaching hospital in Western India. Gujarat Medical Journal, 68(2), 35-39.
36. Sule W, Okonko I, Yumusa I, Odu N and Frank-Peterside N. 2011. Hepatitis B surface antigen (HBsAg) and risk factors of transmission among patients attending hospital in Ankpa, Kogi State, Nigeria. Nature and science, 9, 37-41.
37. Sung F Y, Jung C M, Wu C F, Lin C L, Liu C J, Liaw Y F, Tsai K S and Yu M W. 2009. Hepatitis B virus core variants modify natural course of viral infection and hepatocellular carcinoma progression. Gastroenterology, 137(5), 1687-1697.
38. Trépo C, Chan H L and Lok A. 2014. Hepatitis B virus infection. The Lancet, 384(9959), 2053-2063.
39. Watashi K, Sluder A, Daito T, Matsunaga S, Ryo A, Nagamori S, Iwamoto M, Nakajima S, Tsukuda S and Borroto‐Esoda K. 2014. Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP). Hepatology, 59(5), 1726-1737.
40. Weiss J, Wu H, Farrenkopf B, Schultz T, Song G, Shah S and Siegel J. 2004. Real time TaqMan PCR detection and quantitation of HBV genotypes A-G with the use of an internal quantitation standard. J Clin Virol, 30(1), 86-93.
41. Wu C F, Yu M W, Lin C L, Liu C J, Shih W L, Tsai K S and Chen C J. 2008. Long-term tracking of hepatitis B viral load and the relationship with risk for hepatocellular carcinoma in men. Carcinogenesis, 29(1), 106-112.
42. Yeo W, Mo F K, Chan S L, Leung N W, Hui P, Lam W Y, Mok T S, Lam K C, Ho W M, Koh J, Tang J W, Chan A T and Chan P K. 2007. Hepatitis B viral load predicts survival of HCC patients undergoing systemic chemotherapy. Hepatology, 45(6), 1382-1389.
43. Zauli D A G, Menezes C L P d, Oliveira C L d, Mateo E C C and Ferreira A C d S. 2016. In-house quantitative real-time PCR for the diagnosis of hepatitis B virus and hepatitis C virus infections. brazilian journal of microbiology, 47, 987-992.
44. Zubair M, Anjum Z M, Zafar S, Shamaoon M and Balouch G R. 2010. Frequency of Hepatitis B virus infection among children with chronic liver disease. Annals of Punjab Medical College (APMC), 4(1), 49-52.